American Journal of Kidney Diseases
Volume 55, Issue 1 , Pages 8-10 , January 2010

A Software Upgrade: CKD Testing in 2010

  • Bryan N. Becker, MD, MMM

      Affiliations

    • University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
    • Corresponding Author InformationAddress correspondence to Bryan N. Becker, MD, MMM, J5/223 CSC 600 Highland Ave, Madison,WI 53792
    • ,
  • Joseph A. Vassalotti, MD

      Affiliations

    • National Kidney Foundation, and Mount Sinai School of Medicine, New York, New York

References 

  1. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–612
  2. Vassalotti JA, Stevens LA, Levey AS. Testing for chronic kidney disease: A position statement from the National Kidney Foundation. Am J Kid Dis. 2007;50:169–180
  3. National Kidney Foundation. KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1–S266
  4. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation (Modification of Diet in Renal Disease Study Group). Ann Intern Med. 1999;130:461–470
  5. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–254
  6. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  7. Mitch WE, Walser M, Buffington GA, Lemann J. A simple method of estimating progression of chronic renal failure. Lancet. 1976;2:1326–1328
  8. Nankivell BJ, Gruenewald SM, Allen RD, Chapman JR. Predicting glomerular filtration rate after kidney transplantation. Transplantation. 1995;59:1683–1689
  9. Westfall JM, Mold J, Fagnan L. Practice-based research–“Blue Highways” on the NIH roadmap. JAMA. 2007;297:403–406
  10. NIH News. Larger labs report kidney function routinely. http://www.nih.gov/news/health/oct2008/niddk-10.htmAccessed November 5, 2009
  11. Miller G. Current status of reporting eGFR. http://www.cap.org/apps/docs/committees/chemistry/current_status_reporting_egfr_09.pdfAccessed November 5, 2009
  12. Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ. Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2006;151:492–500
  13. Castro AF, Coresh J. CKD surveillance using laboratory data from the population-based National Health and Nutrition Examination Survey (NHANES). Am J Kidney Dis. 2009;53(suppl 3):S46–S55
  14. Coresh J, Auguste P. Reliability of GFR formulas based on serum creatinine, with special reference to the MDRD Study equation. Scand J Clin Lab Invest Suppl. 2008;241:30–38
  15. Coresh J, Stevens LA. Kidney function estimating equations: where do we stand?. Current Opin Nephrol Hyper. 2006;15:276–284
  16. Levey AS, Coresh J, Greene T, et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53:766–772
  17. Stevens LA, Coresh J, Feldman HI, et al. Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol. 2007;18:2749–2757
  18. Coresh J, Astor BC, McQuillan G, et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 2002;39:920–929
  19. Stevens LA, Manzi J, Levey AS, et al. Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis. 2007;50:21–35
  20. Aakre KM, Tondel C, Brun A, Svarstad E. The MDRD equation may mask decline of glomerular filtration rate in Fabry patients with normal or nearly normal kidney function. Clinical Nephrol. 2009;71:118–124
  21. Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor BC. Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2009;53:596–605
  22. Inaguma D, Tatematsu M, Shinjo H, et al. Relationship between renal function at the time of percutaneous coronary intervention and prognosis in ischemic heart disease patients. Clinical Exp Nephrol. 2007;11:56–60
  23. Kottgen A, Russell SD, Loehr LR, et al. Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol. 2007;18:1307–1315
  24. Obermayr RP, Temml C, Knechtelsdorfer M, et al. Predictors of new-onset decline in kidney function in a general middle-european population. Nephrol Dial Transplant. 2008;23:1265–1273
  25. Ravera M, Noberasco G, Re M, et al. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective. Nephrol Dial Transplant. 2009;24:1528–1533
  26. Eckardt K-U, Berns JS, Rocco MV, Kasiske BL. Definition and classification of CKD: the debate should be about patient prognosis—a position statement from KDOQI and KDIGO. Am J Kidney Dis. 2009;53:915–920
  27. Delanaye P, Cavalier E, Saint-Remy A, Lutteri L, Krzesinski JM. Discrepancies between creatinine-based and cystatin C-based equations in estimating prevalence of stage 3 chronic kidney disease in an elderly population. Scand J Clin Lab Invest. 2009;69:344–349
  28. Hojs R, Bevc S, Ekart R, Gorenjak M, Puklavec L. Serum cystatin C-based equation compared to serum creatinine-based equations for estimation of glomerular filtration rate in patients with chronic kidney disease. Clinical Nephrol. 2008;70:10–17
  29. Rigalleau V, Beauvieux MC, Le Moigne F, et al. Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes. Diabetes Metab. 2008;34:482–489
  30. Sato H, Kazama JJ, Kuroda T, Narita I, Nakano M, Gejyo F. Serum cystatin C measured by a sol particle homogeneous immunoassay can accurately detect early impairment of renal function. Clinical Exp Nephrol. 2008;12:270–276
  31. Tidman M, Sjostrom P, Jones I. A comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two. Nephrol Dial Transplant. 2008;23:154–160
  32. Vupputuri S, Fox CS, Coresh J, Woodward M, Muntner P. Differential estimation of CKD using creatinine- versus cystatin C-based estimating equations by category of body mass index. Am J Kidney Dis. 2009;53:993–1001

PII: S0272-6386(09)01455-3

doi: 10.1053/j.ajkd.2009.11.005

American Journal of Kidney Diseases
Volume 55, Issue 1 , Pages 8-10 , January 2010

Article Tools